These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8750634)
1. Cyclosporine A in chronic lymphocytic leukemia: dual anti-leukemic and immunosuppressive role? Wright SJ; Keating MJ Leuk Lymphoma; 1995 Dec; 20(1-2):131-6. PubMed ID: 8750634 [TBL] [Abstract][Full Text] [Related]
2. Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin. Shimoni A; Shvidel L; Klepfish A; Shtalrid M; Sigler E; Berrebi A Leukemia; 1999 Jan; 13(1):142-3. PubMed ID: 10049051 [No Abstract] [Full Text] [Related]
3. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia. Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014 [TBL] [Abstract][Full Text] [Related]
5. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy]. Tsuji T; Hirano T; Yamasaki H; Tuda H Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883 [TBL] [Abstract][Full Text] [Related]
6. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Karlsson C; Hansson L; Celsing F; Lundin J Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854 [TBL] [Abstract][Full Text] [Related]
8. [An unusual effect of cyclosporine A in a patient with chronic lympholeukemia complicated by autoimmune hemolysis and thrombocytolysis]. Vinogradova OA; Savchenko VG; Parovichnikova EN; Vakhrusheva TL; Ustinova EN Ter Arkh; 1998; 70(7):75-7. PubMed ID: 9742645 [No Abstract] [Full Text] [Related]
10. Cyclosporin A in the treatment of refractory B chronic lymphocytic leukemia (B-CLL). Van Den Neste E; Maerevoet M; Martiat P; Ferrant A; Delannoy A; Michaux JL Leukemia; 1995 Jun; 9(6):1102-3. PubMed ID: 7596177 [TBL] [Abstract][Full Text] [Related]
11. Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia. Pang N; Zhang R; Li J; Zhang Z; Yuan H; Chen G; Zhao F; Wang L; Cao H; Qu J; Ding J Int Immunopharmacol; 2016 Nov; 40():57-64. PubMed ID: 27584054 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia. Sthoeger ZM; Sthoeger D; Shtalrid M; Sigler E; Geltner D; Berrebi A Am J Hematol; 1993 Aug; 43(4):259-64. PubMed ID: 7690517 [TBL] [Abstract][Full Text] [Related]
13. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma. Vick DJ; Byrd JC; Beal CL; Chaffin DJ Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412 [TBL] [Abstract][Full Text] [Related]
15. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia. Tsang M; Parikh SA Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963 [TBL] [Abstract][Full Text] [Related]
16. Evan's syndrome precipitated by fludarabine therapy in a case of CLL. Sen K; Kalaycio M Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320 [No Abstract] [Full Text] [Related]